Mood Disorders

Top Story

FDA advises on medication-assisted treatment for individuals taking depressants

FDA advises on medication-assisted treatment for individuals taking depressants
September 20, 2017

The FDA today issued a Drug Safety Communication advising that buprenorphine and methadone should not be withheld from individuals receiving benzodiazepines or other medications that depress the central nervous system.

The communication also stated that although combined use of these medications increases risk for serious side effects, harm caused by untreated opioid addiction outweighs these risks.

Meeting News

Psych Congress keynote: What you eat affects how you feel

September 16, 2017
NEW ORLEANS — In a keynote address here at Psych Congress, Timothy S. Harlan, MD, FAPC, of Tulane University, discussed the importance of nutrition in…
Meeting News

What to look forward to at Psych Congress

September 14, 2017
The 30th annual Psych Congress will take place in New Orleans from Saturday, Sept. 16 through Tuesday, Sept. 19. As Psych Congress approaches,…
In the Journals

Postpartum depression screening in well-child care lowers maternal depression rates

September 7, 2017
Screening for postpartum depression in well-child care was associated with lower rates of depression and improvements in parenting, anxiety and mental health functioning…
More Headlines »
Feature Article

Mitochondrial Dysfunction and New Therapeutic Targets in Bipolar Affective Disorder

Psychiatric Annals, February 2017, Volume 47 Issue 2
Bipolar affective disorder (BAD) is a complex illness encompassing varying degrees of fluctuating disturbances of…
More »

The Patient with Major Depressive Disorder (MDD)

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with major depressive disorder (MDD).
More »
Resource Centers
Psych Congress

Psych Congress

Meeting News Coverage

VIDEO: Treatment approaches for co-occurring substance use, psychiatric disorders

June 10, 2016
More »